The international segment reported revenue of A$421.4 million, up 33% year-on-year, contributing A$55.8m to normalised earnings before interest and tax, up 91.3%.<\/p>\n
Gross profit for the international segment lifted 47.6% from A$87.4m to A$128.9m, with gross margin lifting 303 basis points from 27.57% to 30.6%.<\/p>\n
The company said New Zealand \u201cled the way\u201d, with sales growth of 20.3% year-on-year and network store sales exceeding $1b.<\/p>\n
Chemist Warehouse has more than 3000 employees in New Zealand.<\/p>\n
\u201cNew Zealand continued to deliver compelling momentum in FY26, reinforcing its position as a significant and scalable growth market for the group,\u201d the company said.<\/p>\n
\u201cThe business opened 14 new stores during the year, including Palmerston North, which delivered the strongest opening sales week ever recorded across the Chemist Warehouse Group globally.\u201d<\/p>\n
Within Sigma Healthcare\u2019s annual report was detail on how it plans to reinforce its growth and momentum in the New Zealand market.<\/p>\n
As of June 30, 2026, six new Chemist Warehouse locations are under construction, bringing the New Zealand network to 81 stores.<\/p>\n
However, the company also noted an additional 20 leases have been signed, providing a pathway to more than 100 stores. No locations were disclosed at this stage.<\/p>\n
To support the planned increase in New Zealand stores, Sigma Healthcare invested about A$40m in May in a new 23,000sq m distribution centre in Auckland.<\/p>\n
The centre is nearly online and expected to start operations next month.<\/p>\n
Sigma Healthcare\u2019s wider group reported total revenue of A$10.8b, up 15.5% year-on-year, with a normalised net profit of A$732.2m, up 22.3%.<\/p>\n